Cerebrospinal fluid penetration of high doses of intravenous ciprofloxacin in meningitis

Clinical Infectious Diseases

Volumn 31, Issue 5, 2000, Pages 1131-1133

  Lipman, J ^a,b   Allworth, A ^a,b   Wallis, S C ^b  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD BRAIN BARRIER; CASE REPORT; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG MEGADOSE; DRUG PENETRATION; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; MENINGITIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SIDE EFFECT;

AGED; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; MENINGITIS, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0034458536     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317462     Document Type: Article

References (16)

1. Ciprofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use
2. The selection of appropriate dosages for intravenous ciprofloxacin
3. Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily
4. Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges
5. Penetration of ciprofloxacin into cerebrospinal fluid of patients with bacterial meningitis
6. Successful treatment of Pseudomonas ventriculitis with ciprofloxacin
7. Ciprofloxacin for Pseudomonas aeruginosa meningitis
8. Successful treatment of enterobacter meningitis with ciprofloxacin
9. Successful treatment of multidrugresistant Pseudomonas aeruginosa meningitis with high-dose ciprofloxacin
10. Penetration of ciprofloxacin into human cerebrospinal fluid in patients with inflamed and non-inflamed meninges
11. Ciprofloxacin in the treatment of gram-negative bacillary meningitis
12. Quinolones in the treatment of infections of the central nervous system
13. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
14. Treatment of severe pneumonia in hospitalized patients: Results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin
15. Pharmacokinetics of high dose intravenous ciprofloxacin in severe sepsis
16. Comparison of high-pressure liquid chromatography and bioassay for determination of ciprofloxacin in serum and urine